Adverse Event Trends Associated with OTC Analgesic and Antipyretic Drug: Data Mining of the Japanese Adverse Drug Event Report Database

被引:3
|
作者
Hasegawa, Shiori [1 ]
Hatahira, Haruna [1 ]
Naganuma, Misa [1 ]
Shimauchi, Akari [2 ]
Sasaoka, Sayaka [1 ]
Motooka, Yumi [1 ]
Fukuda, Akiho [1 ]
Abe, Junko [1 ,3 ]
Nakao, Satoshi [1 ]
Kato, Yamato [1 ]
Ohmori, Tomofumi [4 ]
Iguchi, Kazuhiro [2 ]
Nakamura, Mitsuhiro [1 ]
机构
[1] Gifu Pharmaceut Univ, Lab Drug Informat, 1-25-4 Daigakunishi, Gifu 5011196, Japan
[2] Gifu Pharmaceut Univ, Lab Community Pharm, 1-25-4 Daigakunishi, Gifu 5011196, Japan
[3] Med Database Co LTD, Shibuya Ku, 3-11-10 Higashi, Tokyo 1500011, Japan
[4] Seiyou Trading Co Ltd, Ace Pharm, 7-7-10 Hikie, Gifu 5016133, Japan
关键词
OTC drug; analgesic and antipyretic drug; Japanese Adverse Drug Event Report; TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON-SYNDROME; ALLYLISOPROPYLACETYLUREA; ERUPTION; PHARMACISTS; MEDICATION;
D O I
10.1248/yakushi.17-00120
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OTC drugs play an important role in self-medication. OTC analgesic and antipyretic drugs are widely used in Japan. The present study aimed to survey the components of OTC drug package inserts for analgesic and antipyretic drugs and to evaluate the adverse event profiles using the Japanese Adverse Drug Event Report database (JADER). The JADER contains 430587 reports from between April 2004 and November 2016; a total of 750 reports of adverse events resulted from the use of OTC analgesic and antipyretic drugs. The safety signals were detected by the reporting odds ratio (ROR). The ROR values for "Skin & subcutaneous tissue disorders", "Immune system disorders", and "Hepatobiliary disorders" stratified by system organ class of the Medical Dictionary for Regulatory Activities (Med-DRA) were 7.58 (6.56-8.76), 4.25 (3.51-5.14), and 2.35 (1.93-2.85), respectively. OTC analgesic and antipyretic drugs containing allylisopropylacetylurea (AIAU) exhibited a significantly high reporting ratio of "Skin & subcutaneous tissue disorders" compared with the drugs without AIAU. No difference in the reported incidence of "Hepatobiliary disorders" was found between the drugs with or without acetaminophen. Our results suggested that it was important to monitor patients who use OTC analgesic and antipyretic drug containing AIAU; in particular, careful attention should be paid to skin and subcutaneous tissue disorders.
引用
收藏
页码:1301 / 1311
页数:11
相关论文
共 50 条
  • [31] Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database
    Lianhui Wei
    Ye Tian
    Xiao Chen
    Xiaojing Guo
    Chenxin Chen
    Yi Zheng
    Jinfang Xu
    Xiaofei Ye
    International Journal of Clinical Pharmacy, 2023, 45 : 622 - 629
  • [32] Characteristics of Adverse Events Following Immunization Reporting in Children: The Japanese Adverse Drug Event Report Database
    Noda, Aoi
    Sakai, Takamasa
    Tsuchiya, Masami
    Oyanagi, Gen
    Obara, Taku
    Mano, Nariyasu
    VACCINES, 2020, 8 (03) : 1 - 13
  • [33] Development of the Adverse Analgesic Drug Event Measure
    McDonald, Deborah Dillon
    Ward, Conor
    Zhang, Yiming
    NURSING RESEARCH, 2020, 69 (04) : 299 - 306
  • [34] Evaluation of the Expression Profile of Extrapyramidal Symptoms Due to Antipsychotics by Data Mining of Japanese Adverse Drug Event Report (JADER) Database
    Kose, Eiji
    Uno, Kana
    Hayashi, Hiroyuki
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2017, 137 (01): : 111 - 120
  • [35] Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
    Negishi, Akio
    Oshima, Shinji
    Horii, Norimitsu
    Mutoh, Mizue
    Inoue, Naoko
    Numajiri, Sachihiko
    Ohshima, Shigeru
    Kobayashi, Daisuke
    DRUGS-REAL WORLD OUTCOMES, 2021, 8 (01) : 49 - 61
  • [36] Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
    Akio Negishi
    Shinji Oshima
    Norimitsu Horii
    Mizue Mutoh
    Naoko Inoue
    Sachihiko Numajiri
    Shigeru Ohshima
    Daisuke Kobayashi
    Drugs - Real World Outcomes, 2021, 8 : 49 - 61
  • [37] Central Nervous System Ischemia Associated with Bevacizumab: An Analysis of the Japanese Adverse Drug Event Report Database
    Sugimoto, Shohei
    Ishida, Tomoaki
    Kawada, Kei
    Jobu, Kohei
    Morisawa, Shumpei
    Tamura, Naohisa
    Takuma, Daisuke
    Yoshioka, Saburo
    Miyamuraa, Mitsuhiko
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2022, 45 (12) : 1805 - 1811
  • [38] Disproportionality Analysis of Stomatitis Associated with Anticancer Drugs Using the Japanese Adverse Drug Event Report Database
    Hosonaka, Kousuke
    Yamaoka, Kenta
    Ikeda, Naoe
    Uchida, Mayako
    Uesawa, Yoshihiro
    Takahashi, Kazushige
    Shimizu, Tadashi
    ONCOLOGY, 2024, 102 (09)
  • [39] Adverse Drug Events Caused by Drugs Contraindicated for Coadministration Reported in the Japanese Adverse Drug Event Report Database and Recognized by Reporters
    Negishi, Akio
    Oshima, Shinji
    Horii, Norimitsu
    Mutoh, Mizue
    Inoue, Naoko
    Numajiri, Sachihiko
    Ohshima, Shigeru
    Kobayashi, Daisuke
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2021, 44 (07) : 932 - 936
  • [40] Disproportionality Analysis of Hepatotoxic and Gastrointestinal Adverse Events Associated With Nintedanib Using the Japanese Adverse Drug Event Report (JADER) Database
    Fujiwara, Masaki
    Ikesue, Hiroaki
    Yamaoka, Kenta
    Uchida, Mayako
    Uesawa, Yoshihiro
    Muroi, Nobuyuki
    Shimizu, Tadashi
    IN VIVO, 2025, 39 (01): : 396 - 403